L'équipe du département de pharmacologie

DOMAINES

CONTACT

 

 

 

Université Bordeaux 2 CHU de Bordeaux INSERM
Département Hospitalo-Universitaire de Pharmacologie de Bordeaux
fren

PUBLICATIONS 2015

Dernière mise à jour des publications: 2019-10-07

  1. Methodological Considerations for the Implementation of A European Mandated Retrospective Drug Utilisation Study (Dus) to Investigate the Use of Dexmedetomidine (Dexdor??) in Clinical Practice.
    Value Health. 2015 (18 7) A723
    Stein D, Weatherall M, Garratt C, Aantaa R, Conti G, Lewis MA, Moore N, Gutthann S..
     PubMed citation

  2. Assessment of Burden and Economic Impact of the Vandetanib Restricted Distribution Program in Canada
    Value Health. 2015 (18-7) A484
    Frise S, Bergamasco A, Kozmenko M, Salvo F, Moride Y.
     PubMed citation

  3. Increased Costs Due To Myocardial Infarction (Mi) In France: An Observational Analysis Using A Claims Database.
    Value Health. 2015 (18 7) A386
    Blin P, Philippe F, Laurendeau C, Bouee S, Gourmelen J, Levy Bachelot L, Leproust S, Steg PG..
     PubMed citation

  4. Incidence of Cardiovascular Events Following Myocardial Infarction in France: an Observational Analysis Using a Claims Database.
    Value Health. 2015 (18 7) A382
    Philippe F, Blin P, Laurendeau C, Bouee S, Gourmelen J, Levy Bachelot L, Leproust S, Steg PG..
     PubMed citation

  5. Benefit-Risk of Vka for Atrial Fibrillation Before Doac: a Cohort Study in a Claims and Hospitalization Database.
    Value Health. 2015 (18 7) A381
    Blin P, Dureau-Pournin C, Lassalle R, Abouelfath A, Droz-Perroteau C, Moore N..
     PubMed citation

  6. Validation and Reproducibility of the Updated French Causality Assessment Method: an Evaluation by Pharmacovigilance Centres & Pharmaceutical Companies.
    Therapie. 2015 (70 5) 465-76
    Théophile H, Dutertre JP, Gérardin M, Valnet-Rabier MB, Bidault I, Guy C, Haramburu F, Hillaire-Buys D, Méglio C, Arimone Y..
     PubMed citation

  7. Withdrawal syndrome after co-medication of opioid maintenance therapy with nalmefene: unrecognized interaction.
    Eur J Clin Pharmacol. 2015 (71 12) 1539-40
    Diot C, Eiden C, Roussin A, Batisse A, Boucher A, Chavant F, Daveluy A, Donadieu-Rigole H, Peyri?re H; r?seau des centres fran?ais d??addictovigilance..
     PubMed citation

  8. Choice of ICD-10 codes for the identification of acute coronary syndrome in the French hospitalization database.
    Fundam Clin Pharmacol. 2015 (29 6) 586-91
    Bezin J, Girodet PO, Rambelomanana S, Touya M, Ferreira P, Gilleron V, Robinson P, Moore N, Pariente A..
     PubMed citation

  9. Rivaroxaban and apixaban in orthopaedics: is there a difference in their plasma concentrations and anticoagulant effects?
    Blood Coagul Fibrinolysis. 2015 (26 8) 925-33
    Freyburger G, Macouillard G, Khennoufa K, Labrouche S, Molimard M, Sztark F..
     PubMed citation

  10. Adverse drug reactions and drug-drug interactions with over-the-counter NSAIDs.
    Ther Clin Risk Manag. 2015 (11) 1061-75
    Moore N, Pollack C, Butkerait P..
     PubMed citation

  11. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation.
    Allergy. 2015 (70 11) 1372-92
    Bousquet J, Schunemann HJ, Fonseca J, Samolinski B, Bachert C, Canonica GW, Casale T, Cruz AA, Demoly P, Hellings P, Valiulis A, Wickman M, Zuberbier T, Bosnic-Anticevitch S, Bedbrook A, Bergmann KC, Caimmi D, Dahl R, Fokkens WJ, Grisle I, Lodrup Carlsen K, Mullol J, et al..
     PubMed citation

  12. Utilization of psychotropic drugs by patients consulting for sleeping disorders in homeopathic and conventional primary care settings: the EPI3 cohort study.
    Homeopathy. 2015 (104 3) 170-5
    Grimaldi-Bensouda L, Abenhaim L, Massol J, Guillemot D, Avouac B, Duru G, Lert F, Magnier AM, Rossignol M, Rouillon F, Begaud B; EPI3-LA-SER Group..
     PubMed citation

  13. Risk of neurodevelopmental abnormalities in children treated with propranolol.
    Br J Dermatol. 2015 (173 6) 1562-4
    Labrèze C, Voisard JJ, Delarue A, Moore N..
     PubMed citation

  14. Effect of Centaurium erythraea Rafn, Artemisia herba-alba Asso and Trigonella foenum-graecum L. on liver fat accumulation in C57BL/6J mice with high-fat diet-induced type 2 diabetes.
    J Ethnopharmacol. 2015 (171) 4-11
    Hamza N, Berke B, Cheze C, Marais S, Lorrain S, Abdouelfath A, Lassalle R, Carles D, Gin H, Moore N..
     PubMed citation

  15. Liver transplant associated with paracetamol overdose: results from the seven-country SALT study.
    Br J Clin Pharmacol. 2015 (80 3) 599-606
    Gulmez SE, Larrey D, Pageaux GP, Bernuau J, Bissoli F, Horsmans Y, Thorburn D, McCormick PA, Stricker B, Toussi M, Lignot-Maleyran S, Micon S, Hamoud F, Lassalle R, Jov? J, Blin P, Moore N..
     PubMed citation

  16. Drug use in French children: a population-based study.
    Arch Dis Child. 2015 (100 10) 960-5
    Bénard-Laribière A, Jové J, Lassalle R, Robinson P, Droz-Perroteau C, Noize P..
     PubMed citation

  17. Effects of Cydonia oblonga Miller leaf and fruit flavonoids on blood lipids and anti-oxydant potential in hyperlipidemia rats.
    J Ethnopharmacol. 2015 (169) 239-43
    Umar A, Iskandar G, Aikemu A, Yiming W, Zhou W, Berk? B, Begaud B, Moore N..
     PubMed citation

  18. Traditional Uighur Medicine Karapxa decoction, inhibits liver xanthine oxidase and reduces serum uric acid concentrations in hyperuricemic mice and scavenges free radicals in vitro.
    BMC Complement Altern Med. 2015 (15) 131
    Amat N, Umar A, Hoxur P, Anaydulla M, Imam G, Aziz R, Upur H, Kijjoa A, Moore N..
     PubMed citation

  19. Signal identification in addictovigilance: the functioning of the French system.
    Therapie. 2015 (70 2) 113-31
    Jouanjus E, Gibaja V, Kahn JP, Haramburu F, Daveluy A..
     PubMed citation

  20. Perspectives in Biological Monitoring of Inhaled Nanosized Particles.
    Ann Occup Hyg. 2015 (59 6) 669-80
    Rinaldo M, Andujar P, Lacourt A, Martinon L, Canal Raffin M, Dumortier P, Pairon JC, Brochard P..
     PubMed citation

  21. Statins in pregnancy: new safety data are reassuring, but suspension of treatment is still advisable.
    BMJ. 2015 (350) h1484
    Haramburu F, Daveluy A, Miremont-Salam? G..
     PubMed citation

  22. Antihypertensive drugs, hypotension, and ischemic colitis.
    Am J Cardiovasc Drugs. 2015 (15 2) 77-9
    Blin P..
     PubMed citation

  23. Preventability of adverse effects of analgesics: analysis of spontaneous reports.
    Eur J Clin Pharmacol. 2015 (71 5) 625-9
    Cazacu I, Miremont-Salam? G, Mogosan C, Fourrier-R?glat A, Loghin F, Haramburu F..
     PubMed citation

  24. Is there really a link between benzodiazepine use and the risk of dementia?
    Expert Opin Drug Saf. 2015 (14 5) 733-47
    Billioti de Gage S, Pariente A, B?gaud B..
     PubMed citation

  25. Liver injury with novel oral anticoagulants: assessing post-marketing reports in the US Food and Drug Administration adverse event reporting system.
    Br J Clin Pharmacol. 2015 (80 2) 285-93
    Raschi E, Poluzzi E, Koci A, Salvo F, Pariente A, Biselli M, Moretti U, Moore N, De Ponti F..
     PubMed citation

  26. Drugs and Sleep Apneas? A review of the French Pharmacovigilance database.
    Therapie. 2015 (70 4) 347-50
    Linselle M, Montastruc F, Jantzen H, Valnet-Rabier MB, Haramburu F, Coquerel A, Gouraud A, Perault-Pochat MC, Bagheri H, Montastruc JL..
     PubMed citation

  27. Burnout: evaluation of the efficacy and tolerability of TARGET 1® for professional fatigue syndrome (burnout).
    J Int Med Res. 2015 (43-1) 54-66
    Jacquet A, Grolleau A, Jove J, Lassalle R, Moore N.
     PubMed citation

  28. Burnout: evaluation of the efficacy and tolerability of TARGET 1?? for professional fatigue syndrome (burnout).
    J Int Med Res. 2015 (43 1) 54-66
    Jacquet A, Grolleau A, Jove J, Lassalle R, Moore N..
     PubMed citation

  29. Why are benzodiazepines not yet controlled substances?
    JAMA Psychiatry. 2015 (72 2) 110-1
    Moore N, Pariente A, B?gaud B..
     PubMed citation

  30. Effect of traditional Uyghur medicine abnormal Savda Munziq extract on rabbit platelet aggregation in vitro and rat arteriovenous shunt thrombosis in vivo.
    J Ethnopharmacol. 2015 (159) 184-8
    Umar A, Yimin W, Tohti I, Upur H, Berké B, Moore N.
     PubMed citation

  31. Effect of traditional Uyghur medicine abnormal Savda Munziq extract on rabbit platelet aggregation in vitro and rat arteriovenous shunt thrombosis in vivo.
    J Ethnopharmacol. 2015 (159) 184-8
    Umar A, Yimin W, Tohti I, Upur H, Berk? B, Moore N..
     PubMed citation

  32. Parkinson's disease incidence and prevalence assessment in France using the national healthcare insurance database.
    Eur J Neurol. 2015 (22-3) 464-71
    Blin P, Dureau-Pournin C, Foubert-Samier A, Grolleau A, Corbillon E, Jové J, Lassalle R, Robinson P, Poutignat N, Droz-Perroteau C, Moore N.
     PubMed citation

  33. Parkinson's disease incidence and prevalence assessment in France using the national healthcare insurance database.
    Eur J Neurol. 2015 (22 3) 464-71
    Blin P, Dureau-Pournin C, Foubert-Samier A, Grolleau A, Corbillon E, Jov? J, Lassalle R, Robinson P, Poutignat N, Droz-Perroteau C, Moore N..
     PubMed citation

  34. Inhaler devices for chronic obstructive pulmonary disease: insights from patients and healthcare practitioners.
    J Aerosol Med Pulm Drug Deliv. 2015 (28-3) 219-28
    Molimard M, Colthorpe P.
     PubMed citation

  35. Inhaler devices for chronic obstructive pulmonary disease: insights from patients and healthcare practitioners.
    J Aerosol Med Pulm Drug Deliv. 2015 (28 3) 219-28
    Molimard M, Colthorpe P..
     PubMed citation

  36. Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study.
    Fundam Clin Pharmacol. 2015 (29-1) 106-11
    Bénard-Laribière A, Miremont-Salamé G, Pérault-Pochat MC, Noize P, Haramburu F; EMIR Study Group on behalf of the French network of pharmacovigilance centres.
     PubMed citation

  37. Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study.
    Fundam Clin Pharmacol. 2015 (29 1) 106-11
    Bénard-Laribière A, Miremont-Salamé G, Pérault-Pochat MC, Noize P, Haramburu F; EMIR Study Group on behalf of the French network of pharmacovigilance centres..
     PubMed citation